MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-11-0003959
Doschemen Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹99.96 Lakh
▲ 7% YoY
Net loss · FY 2025
₹4.33 Lakh
Net margin -4.3%
EBITDA · FY 2025
₹78,857
EBITDA margin 0.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹6 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Doschemen Pharmaceuticals Private Limited
Data last updated:
Doschemen Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 03 September 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2014PTC271224. Its GSTIN is 07AAFCD1140E1Z9 (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors Tarvindar Kaur and Devender Pal Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No. 113&114 First Floor Plot No. 3 Jaina Tower District Center Janakpuri, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2025, the company reported a revenue of ₹99.96 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net loss of ₹4.33 Lakh (net margin -4.3%) and EBITDA of ₹78,857 (EBITDA margin 0.8%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 8% over five years.
Doschemen Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0003959). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website doschemen.com.
Company details
CIN U74999DL2014PTC271224
Registration Number 271224
Incorporation Date 03 September 2014
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-11-0003959
Recognitions & Rankings of Doschemen Pharmaceuticals
Contact details
Doschemen Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is doschemen.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No. 113&114 First Floor Plot No. 3 Jaina Tower District Center Janakpuri, New Delhi, Delhi, India – 110058
- IndustryPharma, API Manufacturers
To see the full contact details of Doschemen Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Doschemen Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Doschemen Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Doschemen Pharmaceuticals Private Limited, buy the company report.
Financials of Doschemen Pharmaceuticals Private Limited
FY 2025 filings availableDoschemen Pharmaceuticals Private Limited reported revenue of ₹99.96 Lakh (up 7% YoY) for FY 2025.
Revenue · FY 2025
₹99.96 Lakh ▲ 7%
Net loss · FY 2025
₹4.33 Lakh margin -4.3%
EBITDA · FY 2025
₹78,857 margin 0.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 9%
5 years · compounded
▼ 8%
EBITDA CAGR growth
1 year
▼ 89%
3 years · compounded
▲ 52%
5 years · compounded
▼ 32%
Revenue rose 7% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 8%. EBITDA fell 89% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹78,857 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.33 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | -4.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Doschemen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Doschemen Pharmaceuticals Private Limited
Doschemen Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tarvindar Kaur | Director | 03 Sep 2014 | 12 Years 1 Months | Current |
| Devender Pal Singh Also directs: Surendra Consultancy Services Private Limited | Director | 03 Sep 2014 | 12 Years 1 Months | Current |
Auditor
Doschemen Pharmaceuticals Private Limited is audited by S S PERIWAL & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S S PERIWAL & CO | FY 2022 | 001021N |
Shareholding
The shareholding of Doschemen Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Doschemen Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Doschemen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Doschemen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Doschemen Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCD1140E1Z9 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Doschemen Pharmaceuticals Private Limited, buy the company report.
Recent activity
Doschemen Pharmaceuticals Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Ravi Oberoi ceased to be Additional Director on 10 Sep 2019.
AGM
Doschemen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Doschemen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Ravi Oberoi ceased to be Additional Director.
Appointed
Devender Pal Singh was appointed as Director.
Appointed
Tarvindar Kaur was appointed as Director.
Incorporation
03 Sep 2014
Doschemen Pharmaceuticals Private Limited was registered on 03 Sep 2014 with Roc Delhi Ii & aged 12 years 2 months as per MCA records.
Frequently asked questions
Doschemen Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 03 September 2014 (12+ years old) and is registered under CIN U74999DL2014PTC271224.
Doschemen Pharmaceuticals has 2 current directors:
- Tarvindar Kaur - Director
- Devender Pal Singh - Director
The latest financial statements of Doschemen Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Doschemen Pharmaceuticals is 07AAFCD1140E1Z9, registered in Delhi.
The CIN (Corporate Identification Number) of Doschemen Pharmaceuticals is U74999DL2014PTC271224. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Doschemen Pharmaceuticals was incorporated on 03 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
Ravi Oberoi ceased to be Additional Director on 10 Sep 2019. Devender Pal Singh was appointed as Director on 03 Sep 2014. Tarvindar Kaur was appointed as Director on 03 Sep 2014.
Yes, Doschemen Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0003959).
Doschemen Pharmaceuticals can be reached through the website doschemen.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Doschemen Pharmaceuticals is at Office No. 113&114 First Floor Plot No. 3 Jaina Tower District Center Janakpuri, New Delhi, Delhi, India – 110058.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages